Ligand validation:2ALZ

DCP: 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE

DCP is a Ligand Of Interest in 2ALZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2ALZ_DCP_A_875	77%	30%	0.144	0.986	1.37	1.43	4	6	0	0	100%	1
4FS2_DCP_A_503	87%	36%	0.106	0.977	1.31	1.19	2	4	0	0	100%	1
2DPI_DCP_A_875	76%	24%	0.128	0.966	1.88	1.28	9	6	0	0	100%	1
4EYH_DCP_B_501	50%	52%	0.164	0.913	0.93	0.93	2	-	6	0	100%	1
3Q8P_DCP_B_421	27%	46%	0.192	0.838	0.95	1.12	1	4	9	0	100%	0.8
3EPG_DCP_A_875	25%	14%	0.272	0.909	1.83	2	8	9	7	0	100%	1
3IAY_DCP_A_986	99%	51%	0.058	0.986	0.9	0.98	1	2	2	0	100%	1
4YR0_DCP_A_501	98%	55%	0.067	0.986	0.83	0.91	1	2	0	0	100%	1
2HVW_DCP_C_1203	97%	53%	0.062	0.977	0.86	0.95	1	1	0	0	100%	1
4RZR_DCP_D_401	97%	47%	0.069	0.984	0.84	1.19	-	3	0	0	100%	1
7RBH_DCP_A_402	97%	57%	0.069	0.983	0.83	0.81	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.